BeOne Medicines AG (ONC)

BeOne Medicines AG Revenue

BeOne Medicines AG had revenue of $1.71B in the quarter ending June 30, 2026, with 29.63% growth. This brings the company's total for the last twelve months to $6.13B, up 34.35% year-over-year. In the year 2025, BeOne Medicines AG had annual revenue of $5.34B with 40.23% growth.

• Revenue (ttm): $6.13B
• Revenue Growth: +34.35%
• P/S Ratio: 6.87
• Revenue / Employee: $510,747
• Employees: 12,000
• Market Cap: 43.05B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• BRUKINSA 3.93B 74.7%
• TEVIMBRA 737.30M 14.0%
• XGEVA 305.98M 5.8%
• BLINCYTO 104.22M 2.0%
• KYPROLIS 74.97M 1.4%
• Collaboration 60.97M 1.2%
• POBEVCY 47.40M 0.9%

By Geography

Chart

• U.S. 2.88B 53.9%
• China 1.68B 31.4%
• Europe 611.37M 11.4%
• Rest of World 171.81M 3.2%

Fiscal year ended Dec 31, 2025 See the full BeOne Medicines AG breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.34B	1.53B	40.23%
Dec 31, 2024	3.81B	1.35B	54.96%
Dec 31, 2023	2.46B	1.04B	73.65%
Dec 31, 2022	1.42B	239.64M	20.37%
Dec 31, 2021	1.18B	867.41M	280.83%
Dec 31, 2020	308.87M	-119.34M	-27.87%
Dec 31, 2019	428.21M	229.99M	116.03%
Dec 31, 2018	198.22M	-40.17M	-16.85%
Dec 31, 2017	238.39M	237.32M	22,179.16%
Dec 31, 2016	1.07M	-7.75M	-87.86%
Dec 31, 2015	8.82M	-4.22M	-32.37%
Dec 31, 2014	13.04M	1.89M	16.93%
Dec 31, 2013	11.15M	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error